Trial Information

Summary: This is a study to test a drug that will be used together with your chemotherapy, and is hoped to increase the effectiveness of your chemotherapy.

Patients will be injected with this drug prior to the beginning each cycle of chemotherapy, and will need to take the drug home and either inject themselves or be injected with the drug subcutaneously throughout the remaining 20 days of each cycle.

Inclusion/Exclusion Criteria:

  • Male or Female 18 or over.
  • Confirmed Stage 3B/4 NSCLC.
  • Being treated with paclitaxel and carboplatin

For more information,

Contact:

Anne-Michelle Bakritzes, Study Coordinator
University of Minnesota
420 Delaware Street S.E., MMC 480
Minneapolis, MN 55410
Telephone: +001 612/624-6610
Fax: +001 612/624-7959
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:46:05 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA